Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Viroblock, Diagnoplex, Endosense. Among the most successful fund investment fields, there are Personal Health, Medical Device. The fund has exact preference in some founders of portfolio startups.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Initiative Capital Romandie, startups are often financed by Neomed Management, Ysios Capital, VI Partners AG. The meaningful sponsors for the fund in investment in the same round are BioMedPartners, BB Biotech Ventures, Neomed Management. In the next rounds fund is usually obtained by BioMedPartners, Banexi Ventures, BB Biotech Ventures.
The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Initiative Capital Romandie works on 15 percentage points less the average amount of lead investments. The important activity for fund was in 2013. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2013.
Related Funds
| Fund Name | Location |
| AsiaPay | - |
| Binghong Chuangye | China, Henan, Zhengzhou |
| Edap 2007 | Barcelona, Catalonia, Spain |
| Energia Ventures | Canada, Fredericton, New Brunswick |
| ESB International | County Dublin, Dublin, Ireland |
| Explorer Equity Group | Florida, North Palm Beach, United States |
| Fresh Your Life | Beijing, Beijing, China |
| Gate.io | Illinois, Malta, United States |
| Grosvenor Venture Partners | England, London, United Kingdom |
| Impact Angel Fund | - |
| Market Tech Holdings | Castel, Guernsey, Guernsey |
| Nantong Lanwan Chuangtou | China, Haimen, Jiangsu |
| Neuromuscular Research Association Basel | Basel, Basel-Stadt, Switzerland |
| OPALIC | France, Ile-de-France, Versailles |
| Private Angel Syndicate | - |
| Prototron | Estonia, Harjumaa, Tallinn |
| Qianhe Capital | Beijing, Beijing, China |
| Tesi | Finland, Helsinki, Southern Finland |
| Yantai Yuanjin Investment | China, Jinan, Shandong |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
PicoDRILL | $6M | 01 Aug 2017 | Lausanne, Vaud, Switzerland | ||
Aleva Neurotherapeutics | $18M | 27 May 2016 | Lausanne, Vaud, Switzerland | ||
Endosense | $40M | 27 Nov 2013 | Geneva, Geneva, Switzerland | ||
Aleva Neurotherapeutics | $4M | 10 Apr 2012 | Lausanne, Vaud, Switzerland | ||
Aleva Neurotherapeutics | $11M | 25 Aug 2011 | Lausanne, Vaud, Switzerland | ||
Viroblock | 05 Feb 2010 | Geneva, Switzerland | |||
Viroblock | 20 Jul 2007 | Geneva, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
PicoDRILL | $6M | 01 Aug 2017 | Lausanne, Vaud, Switzerland | ||
Aleva Neurotherapeutics | $18M | 27 May 2016 | Lausanne, Vaud, Switzerland | ||
Endosense | $40M | 27 Nov 2013 | Geneva, Geneva, Switzerland | ||
Aleva Neurotherapeutics | $4M | 10 Apr 2012 | Lausanne, Vaud, Switzerland | ||
Aleva Neurotherapeutics | $11M | 25 Aug 2011 | Lausanne, Vaud, Switzerland | ||
Viroblock | 05 Feb 2010 | Geneva, Switzerland | |||
Viroblock | 20 Jul 2007 | Geneva, Switzerland |
